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 Abstract 
Plant molecular pharming is a promising concept 
based on the large-scale production of recombinant 
proteins encompassing antibodies, vaccines, enzymes 
and peptides for human or veterinary uses and 
treatments. This new branch of the biopharmaceutical 
industry offers practical and safety advantages over other 
traditional production systems. In higher plants, the 
complex cellular machinery makes possible synthesis 
and posttranslational modifications of heterologous 
protein macromolecules. The limiting obstacle to using 
this system at an industrial scale is most often the low 
yield of the recombinant proteins produced in host 
plants. To improve production levels, many studies have 
been focusing on the choice of plant species, tissues, 
organs and cell suspension cultures and/or various 
upstream and downstream constituents in the expression 
cassette. New engineering technologies in plant 
molecular pharming have emerged that rely on the 
usefulness of using soybean agglutinin (SBA), 
hydrophobin, zein and elastin-like peptide tags which are 
employed to extract and purify recombinant proteins in 
 
Received: 12 July 2014 / Accepted revised version: 07 September 2014 / 
Published online: 04 October 2014 
 
© Horizon e-Publishing Group 
 
CITATION 
Makhzoum, A., Tahir, A., Osborn Locke, M. E., Trémouillaux-Guiller, 
J., & Hefferon, K. (2014). An in silico overview on the usefulness of 
tags and linkers in plant molecular pharming. Plant Science Today, 
1(4), 201-212. http://dx.doi.org/10.14719/pst.2014.1.4.72  
 
AUTHOR’S AFFILIATION 
1. Department of Biology, The University of Western Ontario, London, ON 
N6A 5B7, Canada 
2. Quaid-i-Azam University, National Center for Bioinformatics Pakistan 
3. Department of Computer Science, The University of Western Ontario, 
London, ON N6A 5B7, Canada 
4. Université F. Rabelais, Tours, France  
5. Cornell University, Department of Cell Biology and Genetics, United 
States 
 
CORRESPONDENCE 
 Dr. Abdullah Makhzoum, e-mail: E-mail: abmakhzoum@gmail.com 
some host systems and are under the control of different 
expression cassettes. Known to be very useful tools in 
recombinant proteins, linkers separate different domains 
or units of the heterologous gene and thereby retain the 
functionality of the protein of interest. Here, we compare 
computationally one tag SBA as a part of fusion with a 
pharmaceutical human protein ADA joint directly or by 
the specific flexible (GGGGS)3 linker. The in silico analysis 
focuses on the mRNA stability and fusions of tagged and 
tagged-linked ADA recombinant proteins. 
Keywords: plant molecular pharming; adenosine 
deaminase (ADA); soybean agglutinin (SBA); linkers; tags; 
protein fusions 
  
Introduction  
Characteristics of plant molecular pharming 
Genetically engineered plants have emerged as one of 
most attractive platforms for producing therapeutic 
recombinant proteins such as antibodies, vaccines, 
enzymes, and other pharmaceutical entities, such as 
human alpha-1-antitrypsin or human serum albumin, 
necessary for the improvement of veterinary and human 
healthcare systems throughout the world (He et al., 2011; 
Hefferon, 2012; Hefferon, 2014; Ou et al., 2014; Paul, Teh, 
Twyman, & Ma, 2013; Zhang et al., 2012). Plants offer 
scalability, low cost and safety, as they are devoid of 
mammalian pathogens. Moreover, plant cells have the 
capacity to correctly assemble and fold complex proteins 
by providing post-translational modifications 
indispensable to the functionality and stability of foreign 
multimeric proteins (Fu et al., 2014; Ma et al., 2013; 
Stoger, Fischer, Moloney, & Ma, 2014). One drawback to 
the production of pharmaceutical proteins in plants is the 
relatively low yield of protein products that are generated. 
However, maize, wheat, barley and rice are the most 
important cereals capable of producing recombinant 
proteins at high levels ranging from 7 to 10% of total 
soluble protein in seeds (Yang, Wakasa, & Takaiwa, 2008). 
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He and collaborators indicated that the expression levels 
of human serum albumin (HSA) in transgenic rice seeds is 
high enough for downstream and commercialized 
processing (He et al., 2011; Kuo et al., 2013). The rice 
endosperm is capable of accumulating pharmaceutical 
proteins such as human alpha-1-antitrypsin, and thus 
appears to be a promising production platform for 
high-value plant-made pharmaceuticals (Zhang et al., 
2012).  
Plants also offer many host species and culture modes, 
the choice of which, as well as the subcellular 
compartmentalization of the expected protein, is crucial, as 
no single system will be optimal for the expression of all 
recombinant proteins (Paul et al., 2013). Several different 
systems have been investigated, including whole plants, 
seeds, hairy roots, cell suspension cultures and microalgae, 
or still specific cellular organelles such as chloroplasts, in 
order to improve recombinant protein levels (Del et al., 
2012; Makhzoum, Benyammi, Moustafa, & 
Tremouillaux-Guiller, 2013; Makhzoum, Sharma, Bernards, 
& Trémouillaux-Guiller, 2013; Ou et al., 2014; Sabalza, 
Vamvaka, Christou, & Capell, 2013; Skarjinskaia et al., 
2013; Specht & Mayfield, 2014).  
Other approaches used to improve yield production 
To increase the level of targeted proteins in the host 
plant, scientists have been employing other physiological, 
biochemical and molecular approaches (Matic et al., 2012). 
At the gene-transfer-system level, some interesting assays 
have focused on using bacterial plasmids containing 
expression cassettes, while others exploit viral vector 
systems to express heterologous genes and their proteins 
(Hefferon, 2014; Hefferon, 2012). Foreign genes can be 
expressed transiently using specific vectors and/or 
vacuum infiltration-centrifugation based on the stable 
integration of the gene into the chromatin structure 
(Kingsbury & McDonald, 2014; Shah, Almaghrabi, & 
Bohlmann, 2013). For example, in a study conducted by 
Chen and his co-workers on the factors controlling 
biosynthesis and accumulation of the wild and mutated 
human immune-regulatory interleukin-10 transformed in 
Arabidopsis, mutagenized transcripts (at 2762 and at 
3262) demonstrated similar nascent mRNA synthesis but 
improved stability. Likewise, the mutated transcripts from 
plant lines with a more stable and efficient translational 
machinery than the wild IL-10 lines (Chen et al., 2013). 
Innovative genomic and epigenetic approaches in plant 
molecular pharming have recently emerged. Some genome 
re-engineering and epigenetic approaches can have 
tremendous potential through the suppression or decrease 
of protease activities. For example, RNA interference is 
capable of shifting the metabolism of a given host plant 
and can repress the silencers that inhibit the expression of 
transiently transformed genes (Arzola, Chen, Rattanaporn, 
Maclean, & McDonald, 2011; Hakkinen et al., 2013; Rigano, 
De Guzman, Walmsley, Frusciante, & Barone, 2013; 
Tremblay, Diao, Huner, Jevnikar, & Ma, 2011). 
Re-engineering the expression cassette 
The yield of plant-made pharmaceuticals (PMPs) is in 
general low. To overcome this main limiting factor, many 
studies have been conducted to improve the production of 
therapeutic proteins by reengineering the expressed genes 
and proteins at upstream and downstream processing 
levels (Makhzoum et al., 2013; Twyman, Schillberg, & 
Fischer, 2013). Many promoters, codon-optimized ORFs, 
5’UTR, 3’UTR and peptides have been tested to enhance 
the transcription and translation levels and therefore the 
yield production of recombinant proteins (Buyel, Kaever, 
Buyel, & Fischer, 2013; Gallie, 2002; Kanoria & Burma, 
2012; Laguia-Becher et al., 2010). Promoter studies are 
very useful for increasing the expression and accumulation 
of the heterologous pharmaceutical recombinant proteins, 
such as the strong and ubiquitous 35S CaMV promoter, or 
for targeting spatiotemporal expression features by using 
promoters specific to certain cells, tissues or organs 
(Abdullah, Rahmah, Sinskey, & Rha, 2008; Makhzoum et 
al., 2013; Makhzoum, Petit-Paly, St Pierre, & Bernards, 
2011).  
Gene expression can also be enhanced through the 5’ 
UTR regions. In addition to well known translational 
enhancers, including the viral 5’ UTRs Ω and AMV for 
transgene expression in plant systems (especially in dicots 
such as tobacco) (Gallie, 2002), 5’ UTR sequences from the 
photosystem I (PHOTO) gene and the geranyl geranyl 
reductase (GGR) gene in the model plant A. thaliana, have 
shown a high level of GUS expression in comparison to 5’ 
UTR of Ω and AMV. In contrast, the alcohol dehydrogenase 
gene (NtADH) 5’ UTR revealed similar levels of GUS 
expression, nonetheless, this was 30 to 100-fold level 
greater than the control (Agarwal et al., 2014; Satoh, Kato, 
& Shinmyo, 2004). As another example, a new synthetic 
(20 nt) 5’ UTR enabled GUS and GFP reporter gene 
expression to reach levels 10 to 50-fold higher than 
controls in transgenic tobacco and cotton plants. 
Moreover, its promoting role was confirmed either under 
the control of the strong 35S promoter or the weak nos 
promoter (Kanoria & Burma, 2012). In addition to 
improving promoter strength, codon adaptation, 5’UTR 
and 3’UTR choice in expression cassettes, and other 
constituents such as signal peptide tags have been utilized 
to target accumulation to specific organelles in plant cells. 
For example, inclusion of the KDEL endoplasmic reticulum 
retention signal will cause the foreign protein of interest to 
accumulate in the endoplasmic reticulum, where it is 
protected against protease activity present in the cytosol 
(Bundo et al., 2014).  
Targeting recombinant proteins to specific cellular 
compartments is also an important parameter that affects 
plant-made pharmaceutical expression levels. This 
Plant Science Today (2014) 1(4): 201-212 
 
 
ISSN: 2348-1900   Horizon e-Publishing Group 
203  
targeting influences post-translational modifications 
playing a key role on the biological activity and 
accumulation of recombinant proteins in plants 
(Warzecha, 2008). For example the endosperm of rice 
provides an ideal site offering correct folding and adequate 
protection for the foreign protein against proteolysis, 
without any detectable loss of activity (Rademacher et al., 
2008). 
Fusion tags in plant molecular pharming  
Short peptide tags can be fused to constructs harbouring 
foreign genes in order to facilitate recovery during protein 
purification. Some short affinity tags (His tag, Stripe tag, 
Argo tag, and FLAG tag) have been successfully used in 
bacterial and yeast biosynthesis and purification systems 
(Agarwal et al., 2014; Zhao, Li, & Liang, 2013). However, 
the small tags in plant molecular pharming are 
characterized by their ineffectiveness, lack of scalability 
and high cost (Joensuu et al., 2010; Waugh, 2005). Some 
fusion tags have increasingly been gaining more attention 
as a new, effective way of facilitating the expression, 
extraction and purification of pharmaceutical proteins, 
such as hydrophobin (Joensuu et al., 2010; Joensuu, 
Conley, Linder, & Menassa, 2012), zein domain (Alvarez, 
Topal, Martin, & Cardineau, 2010), elastin-like 
polypeptides (Conley, Joensuu, Richman, & Menassa, 2011; 
Floss et al., 2009) and soybean agglutinin (SBA). The SBA 
affinity tag is an effective system which can be used for 
quick and efficient purification of recombinant proteins 
(Tremblay, et al. 2011). Elastin-like polypeptides (ELP) 
were employed by many researchers in recent studies to 
increase the stability and purification yield of human 
immunodeficiency virus (HIV)-neutralizing antibodies 
2G12 (light or heavy chain), transformed and expressed in 
transgenic tobacco plants (with 1% total soluble proteins 
(TSP) from leaves and seeds) (Conley, Joensuu, Jevnikar, 
Menassa, & Brandle, 2009; Floss et al., 2009). Another 
interesting tag is the hydrophobin HFBI gene from 
Trichoderma reesei (hydrophobicity changer) which was 
used as part of a fusion with green fluorescent protein 
(GFP) (GFP- HFBI) and accumulated into protein bodies in 
transiently agro-infiltrated tobacco, with a high yield of 
51% of TSP and a 91% recovery of GFP-HFBI fusion 
protein (Joensuu et al., 2010; Joensuu et al., 2012). The 
Zera® domain, (N-terminal proline-rich domain: γZein 
ER-accumulating domain) of maize Zein gene is able to 
form PB bodies. This domain, in addition to other 
constituents, led to a threefold increase in the Yersinia 
pestis F1-V antigen fusion protein accumulation when 
using the fusion construct, in comparison to the construct 
lacking it, in three separate transient or stable 
transformation systems in Nicotiana benthamiana, 
Medicago sativa (alfalfa) and Nicotiana tabacum NT1 cells 
(Alvarez et al., 2010). To facilitate the removal of these 
tags after purification, the recognition sequence of the 
protease TEV (the sequence Glu-Asn-Leu-Tyr-Phe-Gln- 
(Gly/Ser)(ENLYFQ(G/S)) can be added between the 
protein of interest and the tag (Kapust & Waugh, 2000; 
Tropea, Cherry, & Waugh, 2009; Waugh, 2011). 
Linkers in plant molecular pharming  
Linkers are short peptide sequences that occur between 
protein domains. An important consideration in 
recombinant protein production is the use of linker(s) 
between two fusion genes instead of direct fusion, and is 
showing promise in maintaining protein functionality and 
activity while avoiding interference from other connected 
proteins. On the same expression cassette, linkers are very 
attractive tools for expressing some proteins, ORFs or 
peptides together without perturbing the structure of each 
unit of the fusion or having a negative effect on their 
activity and stability. Linkers are often composed of 
flexible residues such as glycine and serine so that the 
adjacent protein domains are free to move relative to one 
another. Longer linkers are used when it is necessary to 
ensure that two adjacent domains do not sterically 
interfere with one another. Some scientists have agreed 
that short linkers can have a negative effect on SCFV 
antibody folding due to spatial occupancy. Conversely, long 
linkers can influence the functionality and enhance the 
antigenicity of ScFv antibodies (Guo et al., 2006; Le Gall, 
Reusch, Little, & Kipriyanov, 2004; J. Zhang, Yun, Shang, 
Zhang, & Pan, 2009).  
Several short peptides have been used toward this goal. 
For example, the usefulness of the linker EAAAK to design 
a synthetic gene encoding a combination of the 
carboxy-terminal fragment of intimin, the middle region of 
Tir and the carboxy-terminal part of EspA of 
Enterohemorrhagic Escherichia coli O157:H7 (EHEC) has 
been demonstrated, reaching 0.2% to 0.33% TSP in 
transgenic canola seeds, and 0.1% to 0.3% TSP in 
transgenic tobacco lines (Amani, Mousavi, Rafati, & 
Salmanian, 2009, 2011). Another example is the linker AG, 
a simple alanine-glycine linker of six amino acids with 
three AG repeats (AGAGAG). When added between LT-B 
and GFP (green fluorescent protein),using oligonucleotide 
extensions in the PCR (polymerase chain reaction) primers 
as part of the expression cassette in the vectors pLM03, 
pLM08, pLM09 with the percentage of TSP of LT-B::GFP 
being line dependent, and the accumulation went from 
undetectable to 0.059 extracted in maize kernels (Moeller, 
Gan, & Wang, 2009). Modified linkers can improve the 
level of protein accumulation in the case of the FV single 
chain linked to the CH3 of a human anti-rat transfer in 
receptor IgG3 heavy chain by the flexible and optimized 
linker (GGGGS)3, and transformed stably into mammalian 
cells (Trinh, Gurbaxani, Morrison, & Seyfzadeh, 2004). 
Linkers have also been previously designed using a genetic 
algorithm, taking into consideration their lengths, 
flexibilities and compositions (Zhang et al., 2009). For 
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Table 1. Summarize some linkers have used in recombinant proteins and have a good potential to be used in 
plant molecular pharming. The linkers below are generated from the International Genetically Engineered 
Machine (iGEM) Foundation website. 
Name Description Sequence 
Length 
(bp) 
Reference/designer 
BBa_J176131 PLrigid 
(gaagctgctgcaagagaagctgcagctaggg 
Aggctgcagctagggaggctgctgcaaga) 
 
60 
(Merutka, Shalongo, & 
Stellwagen, 1991; Sommese, 
Sivaramakrishnan, Baldwin, 
& Spudich, 2010; Yan, 
Imanishi, Futaki, & Sugiura, 
2007)/ Designed by: 
Karmella Haynes 
Group:Haynes_Lab 
(2011-10-28) 
 
BBa_J18920 2aa GS linker 
(ggcagc) 
 
6 
(Grunberg, Ferrar, van der 
Sloot, Constante, & Serrano, 
2010) 
BBa_J18921 6aa [GS]x linker 
(ggtagcggcagcggtagc) 
 
18 (Grunberg et al., 2010) 
BBa_J18922 10aa [GS]x linker 
(ggtagcggcagcggtagcggtagcggcagc) 
 
30 (Grunberg et al., 2010) 
BBa_K105012 
10 aa flexible protein domain 
linker 
(ggtgaaaatttgtattttcaatctggtggt) 
 
30 
Manuel Gersbacher, Katja 
Karstens Group: 
iGEM08_ESBS-Strasbourg 
(2008-10-19) 
BBa_K133132 8 aa protein domain linker 
(tccgcttgttactgtgagctttcc) 
 
24 
Jan Lonzaric Group: 
iGEM08_Slovenia 
(2008-10-24) 
BBa_K157009 
Split fluorophore linker; Freiburg 
standard 
(cgaccagcctgtaagattccaaatgacctgaa
gcagaaagttatgaatcac) 
 
51 
(Hu, Chinenov, & Kerppola, 
2002; Hu & Kerppola, 2003; 
Kerppola, 2006)/ 
iGEM08_Freiburg 
(2008-10-26) 
BBa_K157013 
15 aa flexible glycine-serine 
protein domain linker; Freiburg 
standard 
(ggtggaggaggttctggaggcggtggaagtgg
tggcggaggtagc) 
 
45 
Kristian Muller Group: 
iGEM08_Freiburg 
(2008-10-26) 
BBa_K243004 Short Linker (Gly-Gly-Ser-Gly) 
(ggtggttctggt) 
 
12 
iGEM09_Freiburg_bioware 
(2009-10-12) 
BBa_K243005 Middle Linker ( Gly-Gly-Ser-Gly)x2 
(ggtggttctggtggtggttctggt) 
 
24 
iGEM09_Freiburg_bioware 
(2009-10-14) 
BBa_K243006 Long Linker (Gly-Gly-Ser-Gly)x3 
(ggtggttctggtggtggttctggtggtggttc
tggt) 
 
36 
iGEM09_Freiburg_bioware 
(2009-10-14) 
BBa_K243029 GSAT Linker 
(ggtggttctgccggtggctccggttctggctc
cagcggtggcagctctggtgcgtccggcacggg
tactgcgggtggcactggcagcggttccggtac
tg 
gctctggc) 
 
108 
iGEM09_Freiburg_bioware 
(2009-10-20) 
BBa_K243030 SEG 
(ggtggttctggcggcggttctgaaggtggcgg
ctccgaaggcggcggcagcgagggcggtggtag
cgaaggtggtggctccgagggtggcggttccgg
108 
iGEM09_Freiburg_bioware 
(2009-10-20) 
more examples about using linkers as part of the 
expression cassette, Soria et al. mentioned several used to 
express chimeric proteins which are comprised of subunit 
vaccines produced in transgenic plants (Soria-Guerra, 
Moreno-Fierros, & Rosales-Mendoza, 2011). 
In silico and computational analysis and optimization  
In molecular pharming as well as many other fields in 
applied molecular biology, gene design and optimization is 
a very useful strategy to enhance protein production yield. 
In order to estimate the quantity, quality and function of 
recombinant proteins, it is necessary to predict gene 
structure optimization, mRNA and protein structure and 
function. For these purposes, gene and protein design 
plays an important role in the quality and activity of 
production yield. Indeed, by using computational tools we 
can study gene structure, mRNA and the activities of 
proteins, as well as predict the yield production of the 
proteins.  
Software such as Visual Gene Developer may help to 
optimize the study of pharmaceutical recombinant genes 
and proteins by analyzing synthetic genes and testing new 
algorithms in bioinformatics (Jung & McDonald, 2011). The 
software can be found and downloaded from 
http://www.visualgenedeveloper.net. 
In silico analysis is a very good tool for the design of new 
drugs and for studying existing vaccines and antibodies, as 
Plant Science Today (2014) 1(4): 201-212 
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BBa_K404300 SEG-Linker 
(ggtggttctggcggcggttctgaaggtggcgg
ctccgaaggcggcggcagcgagggcggtggtag
cgaaggtggtggctccgagggtggcggttccgg
cg 
gcggtagc) 
 
108 
iGEM10_Freiburg_Bioware 
(2010-08-28) 
BBa_K404301 GSAT-Linker 
(ggtggttctgccggtggctccggttctggctc
cagcggtggcagctctggtgcgtccggcacggg
tactgcgggtggcactggcagcggttccggtac
tg 
gctctggc) 
 
108 
iGEM10_Freiburg_Bioware 
(2010-08-28) 
BBa_K404303 Z-EGFR-1907_Short-Linker 
(gtggataacaaatttaacaaagaaatgtgggc
ggcgtgggaagaaattcgtaacctgccgaacct
gaacggctggcagatgaccgcgtttattgcgag
cc 
Tggtggatgatccgagccagagcgcgaacctgc
tggcggaagcgaaaaaactgaacgatgcgcagg
cgccgaaaaccggcggtggttctggt) 
 
192 
iGEM10_Freiburg_Bioware 
(2010-08-28) 
BBa_K404304 Z-EGFR-1907_Middle-Linker 
(gtggataacaaatttaacaaagaaatgtgggc
ggcgtgggaagaaattcgtaacctgccgaacct
gaacggctggcagatgaccgcgtttattgcgag
cc 
tggtggatgatccgagccagagcgcgaacctgc
tggcggaagcgaaaaaactgaacgatgcgcagg
cgccgaaaaccggcggtggttctggtggtggtt
c 
tggt) 
 
204 
(Friedman et al., 2008; 
Gostring et al., 2010)/ 
iGEM10_Freiburg_Bioware 
(2010-08-28) 
BBa_K404305 Z-EGFR-1907_Long-Linker 
(gtggataacaaatttaacaaagaaatgtgggc
ggcgtgggaagaaattcgtaacctgccgaacct
gaacggctggcagatgaccgcgtttattgcgag
cc 
tggtggatgatccgagccagagcgcgaacctgc
tggcggaagcgaaaaaactgaacgatgcgcagg
cgccgaaaaccggcggtggttctggtggtggtt
c 
tggtggtggttctggt) 
 
216 
(Colquhoun & Mellon, 2002; 
Hirsch et al., 2003)/ 
iGEM10_Freiburg_Bioware 
(2010-08-28) 
BBa_K404306 Z-EGFR-1907_SEG-Linker 
(gtggataacaaatttaacaaagaaatgtgggc
ggcgtgggaagaaattcgtaacctgccgaacct
gaacggctggcagatgaccgcgtttattgcgag
cc 
tggtggatgatccgagccagagcgcgaacctgc
tggcggaagcgaaaaaactgaacgatgcgcagg
cgccgaaaaccggcggtggttctggcggcggtt
c 
tgaaggtggcggctccgaaggcggcggcagcga
gggcggtggtagcgaaggtggtggctccgaggg
tggcggttccggcggcggtagc) 
 
288 
(Orlova et al., 2007; Walker & 
Dearing, 1999)/ 
iGEM10_Freiburg_Bioware 
(2010-08-28) 
BBa_K416001 (Gly4Ser)3 Flexible Peptide Linker 
(ggtggaggaggctctggtggaggcggtagcgg
aggcggagggtcg) 
 
45 
iGEM10_NYU (2010-05-29) 
BBa_K648005 
Short Fusion Protein Linker: GGSG 
with standard 25 prefix/suffix 
(ggtggttctggt) 
 
12 
Jim Rose, Alex Bina, Ben 
Alouidor, Brian Avison 
Group: iGEM11_Penn_State 
(2011-07-03) 
BBa_K648006 
Long 10AA Fusion Protein Linker 
with Standard 25 Prefix/Suffix 
(ggtgaaaatttgtattttcaatctggtggt) 
 
30 
Jim Rose, Alex Bina, Ben 
Alouidor, Brian Avison 
Group: iGEM11_Penn_State 
(2011-07-03) 
BBa_K648007 
Medium 6AA Fusion Protein 
Linker: GGSGGS with Standard 25 
Prefix/Suffix 
(ggaggttcaggaggcagc) 
 
18 
Jim Rose Group: 
iGEM11_Penn_State 
(2011-07-03) 
 
it is necessary to optimize drug design by the simulation of 
spatial structures and molecules (Jiang & Zhou, 2005; 
Kamphausen et al., 2002)  
The design of suitable linkers to separate domains of 
biofunctional proteins is an indispensable tool in protein 
engineering (Arai, Ueda, Kitayama, Kamiya, & Nagamune, 
2001). A few scientists have suggested and created a web 
server and software for this purpose, such as ‘‘Linker’’, a 
program to generate linkers for protein fusions (Crasto & 
Feng, 2000). Additionally, a more recent web server, also 
called LINKER, serves to generate peptide sequences with 
extended conformation. Table 1 summarizes some 
potentially useful linkers employed in recombinant protein 
studies by many researchers. These linkers can be studied 
for their positive roles in pharmaceutical plant 
recombinant protein assays and for in silico optimization 
of pharmaceutical protein fusions. 
Based on fusions with or without using linkers, it will be 
interesting to study and show that modified gene and 
protein structures are as stable and functional as their 
natural homologs. As an example, we demonstrate this 
feature using an interesting human enzyme of 
pharmaceutical interest such as human adenosine 
deaminase (ADA). Deficiency in ADA (41 kDa), a crucial 
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Fig. 1. 3D structures of Proteins. (A) SBA-linker-ADA (B) SBA-ADA 
enzyme of the purine salvage pathway, causes a genetically 
inherited disorder of the immune system that can be 
treated by producing functional ADA treatment. This gene 
was empirically expressed and produced in some assays 
such as transgenic tobacco plants and transgenic tobacco 
BY-2 cell suspensions with specific activities of (0.001 and 
0.003 units per mg (TSP) of leaves) and approximately 16 
mg/L in transgenic tobacco BY-2 cell suspensions 
(Singhabahu, George, & Bringloe, 2013, 2014). 
Therefore, as an interesting case study, we attempt to 
compare in silico modeling and design of ADA recombinant 
protein in plant molecular pharming with an SBA tag as a 
fusion with or without a specific linker. The goal of this 
paper is to show the useful role of linkers and tags in plant 
molecular pharming of recombinant proteins and gene 
fusions based on gene structure, mRNA and protein in 
comparison to proteins which lack tags and linkers. We 
compare computationally and predict some features 
leading to pharmaceutical protein yield production such as 
transcription (gene codon and structure optimization, 
mRNA frequency and stability) and translation (protein 
structure and function, stability and instability and 
post-translation). 
Materials and Methods 
Sequence retrieval: 
DNA sequences of linker, SBA and ADA genes were 
obtained from NCBI website 
(http://www.ncbi.nlm.nih.gov/gene). To obtain fused 
proteins, SBA and ADA sequences were joined with and 
without linker. The resulting merged sequences were 
submitted to EXPAY Translate tool 
(http://web.expasy.org/translate/) to achieve protein 
sequences with all possible open reading frames. 
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Functional characterization: 
Physico-chemical properties like molecular weight, 
theoretical IEP (isoelectric point), amino acid composition, 
atomic composition, extinction coefficient, estimated 
half-life, instability index, aliphatic index and grand 
average of hydropathicity (GRAVY) were calculated for 
both proteins using EXAPASY ProtParam server 
(http://web.expasy.org/protparam/). 
Table 2: Functional Characterization of SBA-ADA and SBA-linker-ADA proteins 
Features SBA-ADA SBA-linker-ADA 
Number of Amino Acids 648 664 
Molecular weight 61674 72707.3 
Theoretical pI 5.64 5.64 
Total number of negatively 
charged residues (ASP+GLU) 
77 77 
Total number of positively 
charged residues (ARG+LYS) 
62 62 
Total number of atoms 10086 10214 
Instability Index 35.63 36.68 
Aliphatic Index 90 87.83 
Grand Average Hydropathicity 
(GRAVY) 
-0.221 -0.228 
Ext. Coefficient 86540 86540 
 
Table 3. PROCHECK values for SBA-ADA and SBA-linker-ADA proteins 
Regions SBA-ADA SBA-linker-ADA 
Residues in most favoured regions [A,B,L] 339 
59.3% 
407 
70.7% 
Residues in additional allowed regions [a,b,l,p] 170 
29.7% 
128 
22.2% 
Residues in generously allowed regions[~a,~b,~l,~p] 40 
7.0% 
28 
4.9% 
 
Residues in disallowed regions 
23 
4.0% 
13 
2.3% 
Number of non-glycine and non-proline residues 572 
100% 
576 
100% 
Number of end-residues (excl, Gly and Pro) 2 2 
Number of glycine residues (shown as triangles) 37 49 
Number of proline residues 37 37 
Total Number of Residues 648 664 
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Fig. 2. Ramachandran Plots for SBA-ADA and SBA-linker-ADA 
       
 
Fig. 3. ERRAT Graphs for Proteins. (A) SBA-linker-ADA (B) SBA-ADA 
 
Structure prediction: 
The mRNA structure was predicted using 
(http://www.bioinfo.rpi.edu/applications/mfold). The 
secondary structures for both the proteins were calculated 
using SOPMA (self-optimized prediction method) 
(Geourjon & Deleage, 1995) whereas 3D structures were 
obtained from I-TASSER (Zhang, 2008). Solvent 
accessibility of different residues was evaluated by DSSP 
and other online programs (VADAR) 
(http://redpoll.pharmacy.ualberta.ca/vadar/). 
Structure validation: 
The accurate structure assessment of model’s quality is 
based on biological knowledge and results of analytical 
tools (Vaseeharan & Valli, 2011). For this purpose highly 
prominent tool PROCHECK (Laskowski, Watson, & 
Thornton, 2005) and ERRAT (Colovos & Yeates, 1993) 
were used. 
Results and discussion 
The proteins obtained after translation with maximum 
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amino acid sequences were selected. The functional 
characterization of both proteins is shown in Table 2. The 
hydrophilic nature of protein is associated with a low 
GRAVY value. The GRAVY value for a peptide or protein 
can be calculated as the sum of hydropathy values of all the 
amino acids, divided by the number of residues in the 
sequence. The proteins which have large negative values 
indicated that these proteins had relatively more 
hydropathicity as compared to proteins those possess less 
negative values (Roy, Maheshwari, Chauhan, Sen, & 
Sharma, 2011). The instability index of both proteins was 
calculated less than 40 which classified them as stable 
molecules (Roy et al., 2011) but the protein without a 
linker is slightly more stable as compared to the protein 
with a linker. Similarly, pI values of both proteins were 
determined to be less than 7 indicating an acidic nature. 
The aliphatic index for SBA-ADA is slightly higher than 
SBA-linker-ADA, which suggested that the SBA-ADA has a 
higher thermal stability (Gasteiger et al., 2005; Wilkins et 
al., 1999). The secondary structure analysis of SBA-ADA 
and SBA-linker-ADA describes almost identical results. 
Both proteins have a high number of alpha helices, which 
is as expected because alpha helices are the most common 
structural motifs. The mRNA structure of SBA-linker-ADA 
protein shows a lower energy value of -564.10 kcal/mol, 
which is an attribute of structural stability, whereas the 
value for SBA-ADA is -536.10 kcal/mol.  
The best predicted 3D structures for SBA-ADA and 
SBA-linker-ADA proteins are shown in Fig. 1. The 
structural stability for these proteins is validated through 
different servers. The PROCHECK analysis revealed that 
SBA-linker-ADA protein has a more stable structure than 
SBA-ADA (Fig. 2). The stereochemical properties, including 
Ramachandran plots, G-factor, and the number of bad 
contacts are illustrated in Table 3. The protein with the 
linker has more residues in allowed regions and fewer 
residues in disallowed regions, and similarly has a better 
G-factor value. The statistical analysis of non-bonded 
interactions between different atom types was performed 
using ERRAT 2.0, in a graphical form in Fig. 3. The ERRAT 
score for SBA-linker-ADA is 86.304 which indicates a 
better structure. The solvent accessibility for residues of 
both proteins indicates that SBA-linker-ADA has more 
accessible residues to solvent (Fig. 4). 
Conclusions and perspectives 
The in silico studies on SBA-ADA and SBA-linker-ADA 
proteins suggested that in terms of sequence analysis, 
SBA-ADA is slightly more stable but the overall combined 
sequence (Physico-chemical properties) and structural 
(mRNA and 3D structure) analysis of these proteins 
revealed notable differences 
This in silico analysis illustrates the potential role of tags 
and linkers to increase the yield and the efficacy of 
pharmaceutical recombinant proteins in plant molecular 
pharming. It will be very interesting to extend these 
analyses by employing more tags and linkers based on 
comparative modeling and design to optimize expression 
cassettes and predict the putative effects of these 
constituents on the level of foreign protein production. 
Other tags like hydrophobin, zein and elastin-like peptide 
tags and linkers (Table1 and other linkers) can be studied 
for their suitability and enhancing effects on extracting and 
purifying recombinant proteins in plant host systems.  
Other computational measurements like molecular 
dynamics simulations may also be employed to 
understand time dependent changes in protein linker 
association. Such simulations provide deep understanding 
of protein structure and function at the atomic level.  
References  
Abdullah, M. A., Rahmah, A. U., Sinskey, A. J., & Rha, C. K. (2008). Cell 
engineering and molecular pharming for biopharmaceuticals. 
The Open Medicinal Chemistry Journal, 2, 49-61. 
http://dx.doi.org/10.2174/1874104500802010049  
Agarwal, P., Garg, V., Gautam, T., Pillai, B., Kanoria, S., & Burma, P. K. 
(2014). A study on the influence of different promoter and 
5'UTR (URM) cassettes from Arabidopsis thaliana on the 
expression level of the reporter gene beta glucuronidase in 
tobacco and cotton. Transgenic Research, 23(2), 351-363. 
http://dx.doi.org/10.1007/s11248-013-9757-9  
Alvarez, M. L., Topal, E., Martin, F., & Cardineau, G. A. (2010). 
Higher accumulation of F1-V fusion recombinant protein in 
plants after induction of protein body formation. Plant 
Molecular Biology, 72(1-2), 75-89.  
http://dx.doi.org/10.1007/s11103-009-9552-4  
Amani, J., Mousavi, S. L., Rafati, S., & Salmanian, A. H. (2009). In 
silico analysis of chimeric espA, eae and tir fragments of 
Escherichia coli O157:H7 for oral immunogenic 
applications. Theoretical Biology and Medical Modelling, 6, 
28. http://dx.doi.org/10.1186/1742-4682-6-28   
Amani, J., Mousavi, S. L., Rafati, S., & Salmanian, A. H. (2011). 
Immunogenicity of a plant-derived edible chimeric EspA, 
Intimin and Tir of Escherichia coli O157:H7 in mice. Plant 
Science, 180(4), 620-627. 
http://dx.doi.org/10.1016/j.plantsci.2011.01.004  
Arai, R., Ueda, H., Kitayama, A., Kamiya, N., & Nagamune, T. 
(2001). Design of the linkers which effectively separate 
domains of a bifunctional fusion protein. Protein 
Engineering, 14(8), 529-532. 
http://dx.doi.org/10.1093/protein/14.8.529  
Arzola, L., Chen, J., Rattanaporn, K., Maclean, J. M., & McDonald, K. 
A. (2011). Transient co-expression of post-transcriptional 
gene silencing suppressors for increased in planta 
expression of a recombinant anthrax receptor fusion 
protein. International Journal of Molecular Sciences, 12(8), 
4975-4990. http://dx.doi.org/10.3390/ijms12084975  
Bundo, M., Montesinos, L., Izquierdo, E., Campo, S., Mieulet, D., 
Guiderdoni, E., ... Coca, M. (2014). Production of cecropin A 
antimicrobial peptide in rice seed endosperm. BMC Plant Biology, 
14(1), 102. http://dx.doi.org/10.1186/1471-2229-14-102  
Plant Science Today (2014) 1(4): 201-212 
 
 Horizon e-Publishing Group ISSN: 2348-1900 
210 
Buyel, J. F., Kaever, T., Buyel, J. J., & Fischer, R. (2013). Predictive 
models for the accumulation of a fluorescent marker 
protein in tobacco leaves according to the promoter/5'UTR 
combination. Biotechnol Bioengineering, 110(2), 471-482. 
http://dx.doi.org/10.1002/bit.24715  
Chen, L., Dempsey, B. R., Gyenis, L., Menassa, R., Brandle, J. E., & 
Dhaubhadel, S. (2013). Identification of the factors that 
control synthesis and accumulation of a therapeutic 
protein, human immune-regulatory interleukin-10, in 
Arabidopsis thaliana. Plant Biotechnology Journal, 11(5), 
546-554. http://dx.doi.org/10.1111/pbi.12042  
Colovos, C., & Yeates, T. O. (1993). Verification of protein 
structures: patterns of nonbonded atomic interactions. 
Protein Science, 2(9), 1511-1519. 
http://dx.doi.org/10.1002/pro.5560020916  
Colquhoun, A. J., & Mellon, J. K. (2002). Epidermal growth factor 
receptor and bladder cancer. Postgraduate Medical Journal, 
78(924), 584-589. http://dx.doi.org/10.1136/pmj.78.924.584  
Conley, A. J., Joensuu, J. J., Jevnikar, A. M., Menassa, R., & Brandle, J. 
E. (2009). Optimization of elastin-like polypeptide fusions 
for expression and purification of recombinant proteins in 
plants. Biotechnology and Bioengineering, 103(3), 562-573. 
http://dx.doi.org/10.1002/bit.22278  
Conley, A. J., Joensuu, J. J., Richman, A., & Menassa, R. (2011). 
Protein body-inducing fusions for high-level production 
and purification of recombinant proteins in plants. Plant 
Biotechnol Journal, 9(4), 419-433. 
http://dx.doi.org/10.1111/j.1467-7652.2011.00596.x  
Crasto, C. J., & Feng, J. A. (2000). LINKER: a program to generate linker 
sequences for fusion proteins. Protein Engineering, 13(5), 
309-312. http://dx.doi.org/10.1093/protein/13.5.309  
Del, L. Y. M., Farran, I., Becher, M. L., Sander, V., Sanchez, V. 
R., Martin, V., ... Clemente, M. (2012). A 
chloroplast-derived Toxoplasma gondii GRA4 antigen 
used as an oral vaccine protects against toxoplasmosis 
in mice. Plant Biotechnol Journal, 10(9), 1136-1144. 
http://dx.doi.org/10.1111/pbi.12001  
Floss, D. M., Sack, M., Arcalis, E., Stadlmann, J., Quendler, H., 
Rademacher, T., ... Conrad, U. (2009). Influence of elastin-like 
peptide fusions on the quantity and quality of a tobacco-derived 
human immunodeficiency virus-neutralizing antibody. Plant 
Biotechnol Journal, 7(9), 899-913. 
http://dx.doi.org/10.1111/j.1467-7652.2009.00452.x  
Friedman, M., Orlova, A., Johansson, E., Eriksson, T. L., 
Hoiden-Guthenberg, I., Tolmachev, V., ... Stahl, S. (2008). 
Directed evolution to low nanomolar affinity of a 
tumor-targeting epidermal growth factor receptor-binding 
affibody molecule. Journal of Molecular Biology, 376(5), 
1388-1402. http://dx.doi.org/10.1016/j.jmb.2007.12.060  
Fu, K., Cheng, Q., Liu, Z., Chen, Z., Wang, Y., Ruan, H., ... Yang, D. (2014). 
Immunotoxicity assessment of rice-derived recombinant human 
serum albumin using human peripheral blood mononuclear 
cells. PLoS One, 9(8), e104426. 
http://dx.doi.org/10.1371/journal.pone.0104426  
Gallie, D. R. (2002). The 5'-leader of tobacco mosaic virus 
promotes translation through enhanced recruitment of 
eIF4F. Nucleic Acids Research, 30(15), 3401-3411. 
http://dx.doi.org/10.1093/nar/gkf457  
Gasteiger, E., Hoogland, C., Gattiker, A., Wilkins, M. R., Appel, R. D., 
& Bairoch, A. (2005 ). Protein identification and analysis 
tools on the ExPASy server. In The proteomics protocols 
handbook (pp. 571-607). Humana Press. 
http://dx.doi.org/10.1385/1-59259-890-0:571  
Geourjon, C., & Deleage, G. (1995). SOPMA: significant 
improvements in protein secondary structure prediction by 
consensus prediction from multiple alignments. 
Computational Applied Bioscience, 11(6), 681-684.  
Gostring, L., Chew, M. T., Orlova, A., Hoiden-Guthenberg, I., Wennborg, 
A., Carlsson, J., & Frejd, F. Y. (2010). Quantification of 
internalization of EGFR-binding Affibody molecules: 
Methodological aspects. International Journal of Oncology, 36(4), 
757-763. http://dx.doi.org/10.3892/ijo_00000551  
Grunberg, R., Ferrar, T. S., van der Sloot, A. M., Constante, M., & 
Serrano, L. (2010). Building blocks for protein interaction 
devices. Nucleic Acids Research, 38(8), 2645-2662. 
http://dx.doi.org/10.1093/nar/gkq152  
Guo, J. Q., Li, Q. M., Zhou, J. Y., Zhang, G. P., Yang, Y. Y., Xing, G. X., ... Zhang, 
C. Y. (2006). Efficient recovery of the functional IP10-scFv fusion 
protein from inclusion bodies with an on-column refolding 
system. Protein Expression and Purification, 45(1), 168-174. 
http://dx.doi.org/10.1016/j.pep.2005.05.016  
Hakkinen, S. T., Raven, N., Henquet, M., Laukkanen, M. L., 
Anderlei, T., Pitkanen, J. P., ... Ritala, A. (2013). Molecular 
farming in tobacco hairy roots by triggering the 
secretion of a pharmaceutical antibody. Biotechnology 
and Bioengineering, 111(2), 336–346. 
http://dx.doi.org/10.1002/bit.25113  
He, Y., Ning, T., Xie, T., Qiu, Q., Zhang, L., Sun, Y., ... Yang, D. (2011). 
Large-scale production of functional human serum albumin 
from transgenic rice seeds. Proceedings of the National 
Academy of Sciences USA, 108(47), 19078-19083. 
http://dx.doi.org/10.1073/pnas.1109736108  
Hefferon, K. (2014). Plant virus expression vector development: 
new perspectives. Biomedical Research International, 2014, 
785382. http://dx.doi.org/10.1155/2014/785382  
Hefferon, K. L. (2012). Plant virus expression vectors set the 
stage as production platforms for biopharmaceutical 
proteins. Virology, 433(1), 1-6. 
http://dx.doi.org/10.1016/j.virol.2012.06.012  
Hefferon, K. L. (2014). Broadly neutralizing antibodies and 
the promise of universal vaccines: where are we now? 
Immunotherapy, 6(1), 51-57. 
http://dx.doi.org/10.2217/imt.13.150  
Hirsch, F. R., Varella-Garcia, M., Bunn, P. A., Jr., Di Maria, M. V., 
Veve, R., Bremmes, R. M., ... Franklin, W. A. (2003). 
Epidermal growth factor receptor in non-small-cell lung 
carcinomas: correlation between gene copy number and 
protein expression and impact on prognosis. Journal of 
Clinical Oncology, 21(20), 3798-3807. 
http://dx.doi.org/10.1200/jco.2003.11.069  
Hefferon, K. L. (2012). Plant virus expression vectors set the 
stage as production platforms for biopharmaceutical 
proteins. Virology, 433(1), 1-6. 
http://dx.doi.org/10.1016/j.virol.2012.06.012  
Hirsch, F. R., Varella-Garcia, M., Bunn, P. A., Jr., Di Maria, M. V., 
Veve, R., Bremmes, R. M., ... Franklin, W. A. (2003). 
Epidermal growth factor receptor in non-small-cell lung 
carcinomas: correlation between gene copy number and 
protein expression and impact on prognosis. Journal of 
Clinical Oncology, 21(20), 3798-3807. 
http://dx.doi.org/10.1200/jco.2003.11.069  
Plant Science Today (2014) 1(4): 201-212 
 
 
ISSN: 2348-1900   Horizon e-Publishing Group 
211  
Hu, C. D., Chinenov, Y., & Kerppola, T. K. (2002). Visualization of 
interactions among bZIP and Rel family proteins in living 
cells using bimolecular fluorescence complementation. 
Molecular Cell, 9(4), 789-798. 
http://dx.doi.org/10.1016/S1097-2765(02)00496-3  
Hu, C. D., & Kerppola, T. K. (2003). Simultaneous visualization of 
multiple protein interactions in living cells using multicolor 
fluorescence complementation analysis. Nature Biotechnology, 
21(5), 539-545. http://dx.doi.org/10.1038/nbt816  
Jiang, Z., & Zhou, Y. (2005). Using bioinformatics for drug target 
identification from the genome. American Journal of 
Pharmacogenomics, 5(6), 387-396. 
http://dx.doi.org/10.2165/00129785-200505060-00005  
Joensuu, J. J., Conley, A. J., Lienemann, M., Brandle, J. E., Linder, M. 
B., & Menassa, R. (2010). Hydrophobin fusions for 
high-level transient protein expression and purification in 
Nicotiana benthamiana. Plant Physiology, 152(2), 622-633. 
http://dx.doi.org/10.1104/pp.109.149021  
Joensuu, J. J., Conley, A. J., Linder, M. B., & Menassa, R. 
(2012). Bioseparation of recombinant proteins from 
plant extract with hydrophobin fusion technology. 
Methods in Molecular Biology, 824, 527-534. 
http://dx.doi.org/10.1007/978-1-61779-433-9_28  
Jung, S. K., & McDonald, K. (2011). Visual gene developer: a fully 
programmable bioinformatics software for synthetic gene 
optimization. BMC Bioinformatics, 12, 340. 
http://dx.doi.org/10.1186/1471-2105-12-340  
Kamphausen, S., Holtge, N., Wirsching, F., Morys-Wortmann, C., Riester, 
D., Goetz, R., ... Schwienhorst, A. (2002). Genetic algorithm for the 
design of molecules with desired properties. Journal of 
Computer-Aided Molecular Design, 16(8-9), 551-567. 
http://dx.doi.org/10.1023/A:1021928016359  
Kanoria, S., & Burma, P. K. (2012). A 28 nt long synthetic 5'UTR 
(synJ) as an enhancer of transgene expression in 
dicotyledonous plants. BMC Biotechnology, 12, 85. 
http://dx.doi.org/10.1186/1472-6750-12-85  
Kapust, R. B., & Waugh, D. S. (2000). Controlled intracellular 
processing of fusion proteins by TEV protease. Protein 
Expression and Purification, 19(2), 312-318. 
http://dx.doi.org/10.1006/prep.2000.1251  
Kerppola, T. K. (2006). Design and implementation of 
bimolecular fluorescence complementation (BiFC) assays 
for the visualization of protein interactions in living cells. 
Nature Protocols, 1(3), 1278-1286. 
http://dx.doi.org/10.1038/nprot.2006.201  
Kingsbury, N. J., & McDonald, K. A. (2014). Quantitative 
Evaluation of E1 Endoglucanase Recovery from Tobacco 
Leaves Using the Vacuum Infiltration-Centrifugation 
Method. BioMedical Research International, 2014, 10. 
http://dx.doi.org/10.1155/2014/483596  
Kuo, Y. C., Tan, C. C., Ku, J. T., Hsu, W. C., Su, S. C., Lu, C. A., & 
Huang, L. F. (2013). Improving Pharmaceutical Protein 
Production in Oryza sativa. International Journal of 
Molecular Science, 14(5), 8719-8739. 
http://dx.doi.org/10.3390/ijms14058719  
Laguia-Becher, M., Martin, V., Kraemer, M., Corigliano, M., Yacono, M. L., 
Goldman, A., & Clemente, M. (2010). Effect of codon optimization 
and subcellular targeting on Toxoplasma gondii antigen SAG1 
expression in tobacco leaves to use in subcutaneous and oral 
immunization in mice. BMC Biotechnol,ogy 10, 52. 
http://dx.doi.org/10.1186/1472-6750-10-52  
Laskowski, R. A., Watson, J. D., & Thornton, J. M. (2005). ProFunc: 
a server for predicting protein function from 3D structure. 
Nucleic Acids Research, 33(Web Server issue), W89-93. 
http://dx.doi.org/10.1093/nar/gki414  
Le Gall, F., Reusch, U., Little, M., & Kipriyanov, S. M. (2004). Effect 
of linker sequences between the antibody variable domains 
on the formation, stability and biological activity of a 
bispecific tandem diabody. Protein Engineering, Design and 
Selection, 17(4), 357-366. 
http://dx.doi.org/10.1093/protein/gzh039  
Ma, J. K., Christou, P., Chikwamba, R., Haydon, H., Paul, M., Ferrer, M. P., 
... Thangaraj, H. (2013). Realising the value of plant molecular 
pharming to benefit the poor in developing countries and 
emerging economies. Plant Biotechnology Journal, 11(9), 
1029-1033. http://dx.doi.org/10.1111/pbi.12127  
Makhzoum, A., Benyammi, R., Moustafa, K., & 
Tremouillaux-Guiller, J. (2013). Recent advances on host 
plants and expression cassettes' structure and function in 
plant molecular pharming. BioDrugs, 28, 145-159 
http://dx.doi.org/10.1007/s40259-013-0062-1  
Makhzoum, A., Petit-Paly, G., St Pierre, B., & Bernards, M. A. (2011). 
Functional analysis of the DAT gene promoter using transient 
Catharanthus roseus and stable Nicotiana tabacum 
transformation systems. Plant Cell Reporter, 30(7), 1173-1182. 
http://dx.doi.org/10.1007/s00299-011-1025-y  
Makhzoum, A. B., Sharma, P., Bernards, M. A., & 
Trémouillaux-Guiller, J. (2013). Hairy Roots: An Ideal 
Platform for Transgenic Plant Production and Other 
Promising Applications. Recent Advances in Phytochemistry, 
Volume 42, Phytochemicals, Plant Growth, and the 
Environment, pp. 95-142.  
Matic, S., Masenga, V., Poli, A., Rinaldi, R., Milne, R. G., Vecchiati, 
M., & Noris, E. (2012). Comparative analysis of recombinant 
Human Papillomavirus 8 L1 production in plants by a 
variety of expression systems and purification methods. 
Plant Biotechnology Journal, 10(4), 410-421. 
http://dx.doi.org/10.1111/j.1467-7652.2011.00671.x  
Merutka, G., Shalongo, W., & Stellwagen, E. (1991). A model 
peptide with enhanced helicity. Biochemistry, 30(17), 
4245-4248. http://dx.doi.org/10.1021/bi00231a020  
Moeller, L., Gan, Q., & Wang, K. (2009). A bacterial signal peptide 
is functional in plants and directs proteins to the secretory 
pathway. Journal of Experimental Botany, 60(12), 
3337-3352. http://dx.doi.org/10.1093/jxb/erp167  
Orlova, A., Tolmachev, V., Pehrson, R., Lindborg, M., Tran, T., 
Sandstrom, M., ... Feldwisch, J. (2007). Synthetic affibody 
molecules: a novel class of affinity ligands for molecular 
imaging of HER2-expressing malignant tumors. Cancer 
Research, 67(5), 2178-2186. 
http://dx.doi.org/10.1158/0008-5472.can-06-2887  
Ou, J., Guo, Z., Shi, J., Wang, X., Liu, J., Shi, B., ... Yang, D. (2014). 
Transgenic rice endosperm as a bioreactor for molecular 
pharming. Plant Cell Reporter, 33(4), 585-594. 
http://dx.doi.org/10.1007/s00299-013-1559-2  
Paul, M. J., Teh, A. Y., Twyman, R. M., & Ma, J. K. (2013). Target product 
selection - where can Molecular Pharming make the difference? 
Current Pharmaceutical Design, 19(31), 5478-5485. 
http://dx.doi.org/10.2174/1381612811319310003  
Rademacher, T., Sack, M., Arcalis, E., Stadlmann, J., Balzer, S., 
Altmann, F., ... Stoger, E. (2008). Recombinant antibody 
2G12 produced in maize endosperm efficiently neutralizes 
Plant Science Today (2014) 1(4): 201-212 
 
 Horizon e-Publishing Group ISSN: 2348-1900 
212 
HIV-1 and contains predominantly single-GlcNAc 
N-glycans. Plant Biotechnology Journal, 6(2), 189-201. 
http://dx.doi.org/10.1111/j.1467-7652.2007.00306.x  
Rigano, M. M., De Guzman, G., Walmsley, A. M., Frusciante, L., & Barone, 
A. (2013). Production of pharmaceutical proteins in solanaceae 
food crops. International Journal of Molecular Science, 14(2), 
2753-2773. http://dx.doi.org/10.3390/ijms14022753  
Roy, S., Maheshwari, N., Chauhan, R., Sen, N. K., & Sharma, A. 
(2011). Structure prediction and functional 
characterization of secondary metabolite proteins of 
Ocimum. Bioinformation, 6(8), 315-319. 
http://dx.doi.org/10.6026/97320630006315  
Sabalza, M., Vamvaka, E., Christou, P., & Capell, T. (2013). Seeds as a 
production system for molecular pharming applications: status 
and prospects. Current Pharmaceutical Design, 19(31), 5543-5552. 
http://dx.doi.org/10.2174/1381612811319310009  
Satoh, J., Kato, K., & Shinmyo, A. (2004). The 5'-untranslated 
region of the tobacco alcohol dehydrogenase gene functions 
as an effective translational enhancer in plant. Journal of 
Bioscience and Bioengineering, 98(1), 1-8. 
http://dx.doi.org/10.1016/s1389-1723(04)70234-0  
Shah, K., Almaghrabi, B., & Bohlmann, H. (2013). Comparison 
of Expression Vectors for Transient Expression of 
Recombinant Proteins in Plants. Plant Molecular 
Biology Reporter, 31(6), 1529-1538. 
http://dx.doi.org/10.1007/s11105-013-0614-z  
Singhabahu, S., George, J., & Bringloe, D. (2013). Expression of a 
functional human adenosine deaminase in transgenic 
tobacco plants. Transgenic Research, 22(3), 643-649. 
http://dx.doi.org/10.1007/s11248-012-9676-1  
Singhabahu, S., George, J., & Bringloe, D. (2014). High yield 
production of apoplast-directed human adenosine 
deaminase in transgenic tobacco BY-2 cell suspensions. 
Biotechnology and Applied Biochemistry. Article first 
published online: 14 JUL 2014 
http://dx.doi.org/10.1002/bab.1240  
Skarjinskaia, M., Ruby, K., Araujo, A., Taylor, K., Gopalasamy-Raju, 
V., Musiychuk, K., ... Yusibov, V. (2013). Hairy roots as a 
vaccine production and delivery system. Advances in 
Biochemical Engineering/Biotechnology, 134, 115-134. 
http://dx.doi.org/10.1007/10_2013_184  
Sommese, R. F., Sivaramakrishnan, S., Baldwin, R. L., & Spudich, J. 
A. (2010). Helicity of short E-R/K peptides. Protein Science, 
19(10), 2001-2005. http://dx.doi.org/10.1002/pro.469  
Soria-Guerra, R. E., Moreno-Fierros, L., & Rosales-Mendoza, S. (2011). 
Two decades of plant-based candidate vaccines: a review of the 
chimeric protein approaches. Plant Cell Reporter, 30(8), 
1367-1382. http://dx.doi.org/10.1007/s00299-011-1065-3  
Specht, E. A., & Mayfield, S. P. (2014). Algae-based oral 
recombinant vaccines. Frontiers in Microbiology, 5, 60. 
http://dx.doi.org/10.3389/fmicb.2014.00060  
Stoger, E., Fischer, R., Moloney, M., & Ma, J. K. (2014). Plant molecular 
pharming for the treatment of chronic and infectious diseases. 
Annual Review of Plant Biology, 65, 743-768. 
http://dx.doi.org/10.1146/annurev-arplant-050213-035850  
Tremblay, R., Diao, H., Huner, N., Jevnikar, A. M., & Ma, S. (2011). The 
development of a high-yield recombinant protein bioreactor 
through RNAi induced knockdown of ATP/ADP transporter in 
Solanum tuberosum. Journal of Biotechnology, 156(1), 59-66. 
http://dx.doi.org/10.1016/j.jbiotec.2011.08.005  
Trinh, R., Gurbaxani, B., Morrison, S. L., & Seyfzadeh, M. (2004). 
Optimization of codon pair use within the (GGGGS)3 linker 
sequence results in enhanced protein expression. 
Molecular Immunology, 40(10), 717-722. 
http://dx.doi.org/10.1016/j.molimm.2003.08.006  
Tropea, J. E., Cherry, S., & Waugh, D. S. (2009). Expression and 
purification of soluble His(6)-tagged TEV protease. Methods 
in Molecular Biology, 498, 297-307. 
http://dx.doi.org/10.1007/978-1-59745-196-3_19  
Twyman, R. M., Schillberg, S., & Fischer, R. (2013). Optimizing the 
yield of recombinant pharmaceutical proteins in plants. 
Current Pharmaceutical Design, 19(31), 5486-5494. 
http://dx.doi.org/10.2174/1381612811319310004  
Vaseeharan, B., & Valli, S. J. (2011 ). In silico homology modeling 
of prophenoloxidase activating factor Serine Proteinase 
gene from the haemocytes of Fenneropenaeus indicus. 
Journal of Proteomics and Bioinformatics, 4, 053-057.  
Walker, R. A., & Dearing, S. J. (1999). Expression of epidermal growth 
factor receptor mRNA and protein in primary breast 
carcinomas. Breast Cancer Research and Treatment, 53(2), 
167-176. http://dx.doi.org/10.1023/A:1006194700667  
Warzecha, H. (2008). Biopharmaceuticals from plants: a 
multitude of options for posttranslational modifications. 
Biotechnology & Genetic Engineering Reviews, 25, 315-330. 
http://dx.doi.org/10.5661/bger-25-315  
Waugh, D. S. (2005). Making the most of affinity tags. Trends in 
Biotechnology, 23(6), 316-320. 
http://dx.doi.org/10.1016/j.tibtech.2005.03.012  
Waugh, D. S. (2011). An overview of enzymatic reagents for the 
removal of affinity tags. Protein Expression and Purification, 
80(2), 283-293. http://dx.doi.org/10.1016/j.pep.2011.08.005  
Wilkins, M. R., Gasteiger, E., Bairoch, A., Sanchez, J. C., Williams, K. 
L., Appel, R. D., & Hochstrasser, D. F. (1999). Protein 
identification and analysis tools in the ExPASy server. 
Methods in Molecular Biology, 112, 531-552.  
Yan, W., Imanishi, M., Futaki, S., & Sugiura, Y. (2007). 
Alpha-helical linker of an artificial 6-zinc finger peptide 
contributes to selective DNA binding to a discontinuous 
recognition sequence. Biochemistry, 46(29), 8517-8524. 
http://dx.doi.org/10.1021/bi7006417  
Yang, L., Wakasa, Y., & Takaiwa, F. (2008). Biopharming to 
increase bioactive peptides in rice seed. Journal of AOAC 
International, 91(4), 957-964.  
Zhang, J., Yun, J., Shang, Z., Zhang, X., & Pan, B. (2009). Design and 
optimization of a linker for fusion protein construction. 
Progress in Natural Science, 19(10), 1197-1200. 
http://dx.doi.org/http://dx.doi.org/10.1016/j.pnsc.2008.12.007  
Zhang, L., Shi, J., Jiang, D., Stupak, J., Ou, J., Qiu, Q., ... Yang, D. 
(2012). Expression and characterization of recombinant 
human alpha-antitrypsin in transgenic rice seed. Journal of 
Biotechnology, 164(2), 300-308. 
http://dx.doi.org/10.1016/j.jbiotec.2013.01.008  
Zhang, Y. (2008). I-TASSER server for protein 3D structure 
prediction. BMC Bioinformatics, 9, 40. 
http://dx.doi.org/10.1186/1471-2105-9-40   
Zhao, X., Li, G., & Liang, S. (2013). Several Affinity Tags Commonly 
Used in Chromatographic Purification. Journal of Analytical 
Methods in Chemistry, 2013, 581093. 
http://dx.doi.org/10.1155/2013/581093  
 
